Heather Bresch

Heather Bresch is an American business executive known for her role as the CEO of Mylan, a global pharmaceutical company. She gained significant attention for leading the company through controversies over the pricing of the epinephrine auto-injector, EpiPen, which sparked public outcry due to steep price increases. Bresch has a background in international politics and business and has focused on making healthcare more accessible. Under her leadership, Mylan expanded its product portfolio and aimed to improve access to medications, though her tenure also brought scrutiny regarding corporate ethics in the pharmaceutical industry.